查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1602706

苯磺酸氨氯地平市場：按類型、應用分類 - 全球預測 2025-2030

Amlodipine Besylate Market by Type (10 mg Tablets, 2.5 mg Tablets, 5 mg Tablets), Application (Heart Diseases, High Blood Pressure) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年苯磺酸氨氯地平市值為41337萬美元，預計2024年將達到43728萬美元，複合年成長率為6.18%，預計2030年將達到62905萬美元。

苯磺酸氨氯地平是一種鈣拮抗劑，廣泛用於治療高血壓和冠狀動脈疾病。對苯磺酸氨氯地平的需求是因為它能有效控制這些疾病並降低心臟病發作、中風和腎臟損傷的風險。苯磺酸氨氯地平主要用於製藥領域，最終用途包括醫院藥局、零售藥局和網路藥局。苯磺酸氨氯地平市場受到心血管疾病盛行率上升、人口老化以及預防保健意識增強的影響。特別是在發展中地區，由於醫療基礎設施的改善和藥品取得範圍的擴大，這一趨勢正在加速。主要商機在於由於成本優勢和品牌藥專利到期對學名藥藥苯磺酸氨氯地平的需求增加。市場相關人員可能會透過加強分銷網路和開拓新興市場（特別是亞太地區和拉丁美洲）而受益。挑戰包括嚴格的監管政策、潛在的副作用以及來自替代療法和文明病治療的競爭。此外，學名藥市場的飽和對盈利構成威脅。藥物傳遞的創新可以集中在改進緩釋性、同時針對多種疾病的聯合治療，並透過經皮貼片和奈米顆粒等新的藥物傳遞系統來提高患者的依從性。對個人化醫療方法的研究也可能提供差異化產品並佔領利基市場。儘管市場本質上競爭激烈，眾多學名藥壓低了價格，但公司仍有機會利用技術進步和戰略夥伴關係關係來開拓開拓的市場。總體而言，雖然市場格局面臨挑戰，但透過策略創新和適應不斷變化的醫療保健格局，存在巨大的成長機會。

主要市場統計
基準年[2023] 41337萬美元
預測年份 [2024] 43728萬美元
預測年份 [2030] 62905萬美元
複合年成長率（%） 6.18%

市場動態：快速發展的苯磺酸氨氯地平市場的關鍵市場洞察

苯磺酸氨氯地平市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 高血壓和心臟病盛行率上升
    • 苯磺酸氨氯地平在各種治療的使用增加
    • 冠狀動脈疾病治療指引的執行
  • 市場限制因素
    • 氨氯地平替代品的可用性
  • 市場機會
    • 更多採用快速檢測和照護現場診斷
    • 加大氨氯地平研發投入
  • 市場挑戰
    • 對苯磺酸氨氯地平副作用的擔憂

波特的五力：駕馭苯磺酸氨氯地平市場的策略工具

波特的五力架構是了解苯磺酸氨氯地平市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解苯磺酸氨氯地平市場的外部影響

外部宏觀環境因素在塑造苯磺酸氨氯地平市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解苯磺酸氨氯地平市場的競爭格局

對苯磺酸氨氯地平市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 苯磺酸氨氯地平市場定位矩陣供應商績效評估

FPNV定位矩陣是評估苯磺酸氨氯地平市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製苯磺酸氨氯地平市場的成功之路

苯磺酸氨氯地平市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：全面分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 高血壓和心臟病的發生率增加
      • 苯磺酸氨氯地平在各種治療的使用增加
      • 冠心病治療指出的實施
    • 抑制因素
      • 氨氯地平替代品的可用性
    • 機會
      • 快速檢測的興起和照護現場診斷的引入
      • 增加對苯磺酸氨氯地平研發活動的投資
    • 任務
      • 關於苯磺酸氨氯地平副作用的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章苯磺酸氨氯地平市場：依類型

  • 10毫克片劑
  • 2.5毫克片劑
  • 5毫克片劑

第7章苯磺酸氨氯地平市場：依應用分類

  • 心臟病
  • 高血壓

第8章 苯磺酸氨氯地平北美、南美市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區苯磺酸氨氯地平市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲苯磺酸氨氯地平市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Cadila Pharmaceuticals Limited
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co., Ltd.
  • Chartwell Pharmaceuticals LLC
  • Cipla Inc.
  • Dr. Reddys Laboratories Ltd.
  • Lupin Limited
  • MOEHS IBERICA, SL
  • Orbion Pharmaceuticals Private Limited
  • Pfizer Inc.
  • Sanofi SA
  • Strides Pharma Science Limited
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-742BD517AAF1

The Amlodipine Besylate Market was valued at USD 413.37 million in 2023, expected to reach USD 437.28 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 629.05 million by 2030.

Amlodipine Besylate, a calcium channel blocker, is extensively used for treating hypertension and coronary artery disease. The necessity of Amlodipine Besylate stems from its efficacy in managing these conditions, reducing the risk of heart attacks, strokes, and kidney problems. It's primarily applied in the pharmaceutical sector, with end-use spanning hospital pharmacies, retail pharmacies, and online pharmacies. The market for Amlodipine Besylate is influenced by the rising prevalence of cardiovascular diseases, an aging population, and increasing awareness around preventative healthcare. Notably, there is a growing trend in developing regions due to improved healthcare infrastructure and expanding access to medications. A key opportunity lies in the increasing demand for generic versions of Amlodipine Besylate, driven by cost advantages and patent expirations of branded drugs. Market players could benefit by enhancing distribution networks and tapping into emerging markets, particularly in Asia-Pacific and Latin America. Challenges include stringent regulatory policies, potential side effects, and competition from alternative therapies and lifestyle interventions. Additionally, generic market saturation poses a threat to profitability. Innovations could focus on improving the drug's formulation for sustained release, combination therapies to target multiple ailments concurrently, and enhancing patient compliance through novel drug delivery systems like transdermal patches or nanoparticles. Research into personalized medicine approaches could also offer differentiated products, capturing niche market segments. The market is inherently competitive, with numerous generics driving down prices, but opportunities exist for companies that can leverage technological advancements and strategic partnerships to enter underserved markets. Overall, while the Amlodipine Besylate market faces challenges, there are substantial opportunities for growth through strategic innovation and adaptation to the evolving healthcare landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 413.37 million
Estimated Year [2024] USD 437.28 million
Forecast Year [2030] USD 629.05 million
CAGR (%) 6.18%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Amlodipine Besylate Market

The Amlodipine Besylate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of hypertension and heart diseases
    • Increasing usage of amlodipine besylate in various treatments
    • Implementation of guidelines for coronary artery disease treatment
  • Market Restraints
    • Availability of alternative medications to amlodipine
  • Market Opportunities
    • Emerging adoption of rapid testing and point-of-care diagnosis
    • Increasing investments in research and development activities of amlodipine besylate
  • Market Challenges
    • Concerns associated with side effects of amlodipine besylate

Porter's Five Forces: A Strategic Tool for Navigating the Amlodipine Besylate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Amlodipine Besylate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Amlodipine Besylate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Amlodipine Besylate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Amlodipine Besylate Market

A detailed market share analysis in the Amlodipine Besylate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Amlodipine Besylate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Amlodipine Besylate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Amlodipine Besylate Market

A strategic analysis of the Amlodipine Besylate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Amlodipine Besylate Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Aurobindo Pharma Limited, Cadila Pharmaceuticals Limited, Century Pharmaceuticals Ltd., Changzhou Yabang Pharmaceutical Co., Ltd., Chartwell Pharmaceuticals LLC, Cipla Inc., Dr. Reddys Laboratories Ltd., Lupin Limited, MOEHS IBERICA, SL, Orbion Pharmaceuticals Private Limited, Pfizer Inc., Sanofi S.A., Strides Pharma Science Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Amlodipine Besylate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across 10 mg Tablets, 2.5 mg Tablets, and 5 mg Tablets.
  • Based on Application, market is studied across Heart Diseases and High Blood Pressure.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of hypertension and heart diseases
      • 5.1.1.2. Increasing usage of amlodipine besylate in various treatments
      • 5.1.1.3. Implementation of guidelines for coronary artery disease treatment
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of alternative medications to amlodipine
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of rapid testing and point-of-care diagnosis
      • 5.1.3.2. Increasing investments in research and development activities of amlodipine besylate
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with side effects of amlodipine besylate
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Amlodipine Besylate Market, by Type

  • 6.1. Introduction
  • 6.2. 10 mg Tablets
  • 6.3. 2.5 mg Tablets
  • 6.4. 5 mg Tablets

7. Amlodipine Besylate Market, by Application

  • 7.1. Introduction
  • 7.2. Heart Diseases
  • 7.3. High Blood Pressure

8. Americas Amlodipine Besylate Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Amlodipine Besylate Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Amlodipine Besylate Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Inc.
  • 2. Aurobindo Pharma Limited
  • 3. Cadila Pharmaceuticals Limited
  • 4. Century Pharmaceuticals Ltd.
  • 5. Changzhou Yabang Pharmaceutical Co., Ltd.
  • 6. Chartwell Pharmaceuticals LLC
  • 7. Cipla Inc.
  • 8. Dr. Reddys Laboratories Ltd.
  • 9. Lupin Limited
  • 10. MOEHS IBERICA, SL
  • 11. Orbion Pharmaceuticals Private Limited
  • 12. Pfizer Inc.
  • 13. Sanofi S.A.
  • 14. Strides Pharma Science Limited
  • 15. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. AMLODIPINE BESYLATE MARKET RESEARCH PROCESS
  • FIGURE 2. AMLODIPINE BESYLATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AMLODIPINE BESYLATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AMLODIPINE BESYLATE MARKET DYNAMICS
  • TABLE 7. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 10 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 2.5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY 5 MG TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AMLODIPINE BESYLATE MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES AMLODIPINE BESYLATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM AMLODIPINE BESYLATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AMLODIPINE BESYLATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. AMLODIPINE BESYLATE MARKET, FPNV POSITIONING MATRIX, 2023